ITM is thought to represent a distinct feature even in the “post-aquaporin-4 (AQP4) antibody era” [2], especially in East Asia, where the incidence of multiple sclerosis and neurosarcoidosis is very low. This evidence concerns the gene AQP4 and neurosarcoidosis.